GlaxoSmithKline PLC
NYSE:GSK
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
34.0708
45.78
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
GlaxoSmithKline PLC
Total Current Liabilities
GlaxoSmithKline PLC
Total Current Liabilities Peer Comparison
INDV
HIK
AGY
DPH
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
GlaxoSmithKline PLC
NYSE:GSK
|
Total Current Liabilities
£20.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
A
|
AstraZeneca PLC
NASDAQ:AZN
|
Total Current Liabilities
$28.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
|
|
Indivior PLC
LSE:INDV
|
Total Current Liabilities
$1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Total Current Liabilities
$1.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
1%
|
CAGR 10-Years
9%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Total Current Liabilities
£25.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Total Current Liabilities
£164m
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
5%
|
See Also
What is GlaxoSmithKline PLC's Total Current Liabilities?
Total Current Liabilities
20.3B
GBP
Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Total Current Liabilities amounts to 20.3B GBP.
What is GlaxoSmithKline PLC's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
5%
Over the last year, the Total Current Liabilities growth was -8%. The average annual Total Current Liabilities growth rates for GlaxoSmithKline PLC have been -2% over the past three years , -5% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
